xEVMPD management | ASPHALION SERVICE “MINI PILL”

xEVMPD management is the Extended Eudravigilance Medicinal Product Dictionary of the European Medicinal Agency (EMA), which defines controlled vocabulary to be used for the marketing authorisation of medicinal products.

xEVMPD management is the Extended Eudravigilance Medicinal Product Dictionary of the European Medicinal Agency (EMA), which defines controlled vocabulary to be used for the marketing authorisation of medicinal products.
December 12, 2022

The submission of data on medicines by marketing authorisation holders is a legal requirement from Article 57(2) of Regulation (EC) No. 726/2004, as amended by Regulation (EU) 1235/2010 and Regulation (EU) 1027/2012.

At Asphalion we have a dedicated team, fully trained and greatly experienced in supporting the activities related to xEVMPD. Proactively, we provide pre-filled templates that ease providing the required information for the creation and maintenance of data. We offer a quick and efficient solution that allows you to be compliant and on time.

Check out our #serviceminipill to see how ASPHALION can help you with the xEVMPD management!!

You can check out all pharmaceutical data management services here: DATA MANAGEMENT

For further information, please contact us at: info@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | 20th Biosimilar Medicines Conference by MFE

During these two interactive days, actors of the healthcare community alongside world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and emerging trends. Discussion will focus on sharing good practices and setting collective aims to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to untap their transformative value.

New opening! | Pamplona office

At Asphalion, we are thrilled to announce the opening of our new office in Pamplona! This strategic decision reflects our commitment to being closer to

BUSINESS CASE | Transparency policy 0070

Have a look at this Business Case where Asphalion provided a leading global pharmaceutical company with full regulatory support for the management of Policy 0070

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting